Artificial disc replacement devices will lead non-fusion spinal devices sales through 2036 with a 49.0% share, driven by growing surgeon and patient preference for motion-preserving alternatives to spinal fusion. Hospitals hold a 61.0% share. The market is set to reach USD 4.9 billion by 2026-end and USD 7.5 billion by 2036.